ZA961948B - 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof - Google Patents

6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof

Info

Publication number
ZA961948B
ZA961948B ZA961948A ZA961948A ZA961948B ZA 961948 B ZA961948 B ZA 961948B ZA 961948 A ZA961948 A ZA 961948A ZA 961948 A ZA961948 A ZA 961948A ZA 961948 B ZA961948 B ZA 961948B
Authority
ZA
South Africa
Prior art keywords
aryl
ones
compositions
methods
Prior art date
Application number
ZA961948A
Other languages
English (en)
Inventor
Edward R Bacon
Baldev Singh
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of ZA961948B publication Critical patent/ZA961948B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA961948A 1995-03-10 1996-03-11 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof ZA961948B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40226195A 1995-03-10 1995-03-10

Publications (1)

Publication Number Publication Date
ZA961948B true ZA961948B (en) 1996-09-17

Family

ID=23591191

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961948A ZA961948B (en) 1995-03-10 1996-03-11 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof

Country Status (13)

Country Link
US (2) US5736548A (cs)
EP (1) EP0813534A4 (cs)
JP (1) JPH11501926A (cs)
KR (1) KR19980702892A (cs)
AU (1) AU708809B2 (cs)
CA (1) CA2211729A1 (cs)
CZ (1) CZ280697A3 (cs)
HU (1) HUP9801394A3 (cs)
NO (1) NO974150L (cs)
NZ (1) NZ303886A (cs)
PL (1) PL322452A1 (cs)
WO (1) WO1996028448A1 (cs)
ZA (1) ZA961948B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664261B2 (en) 1996-02-07 2003-12-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines as CRF receptor antagonists
DE19709877A1 (de) * 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
BR9810233A (pt) 1997-04-25 2000-10-17 Pfizer Pirozolpirimidinonas que inibem fosfodiesterase da guanosina 3`, 5`- monosfofato cìclico do tipo 5 (cgmp pde5) para o tratamento da disfunção sexual.
GB9722520D0 (en) 1997-10-24 1997-12-24 Pfizer Ltd Compounds
EA200000969A1 (ru) * 1998-04-20 2001-06-25 Пфайзер Инк. ИНГИБИТОРЫ цГМБ ФДЭ5 НА ОСНОВЕ ПИРАЗОЛПИРИМИДИНОНА ДЛЯ ЛЕЧЕНИЯ ПОЛОВЫХ ДИСФУНКЦИЙ
GB9823102D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
GB9823103D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
GB9823101D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
US6225315B1 (en) 1998-11-30 2001-05-01 Pfizer Inc Method of treating nitrate-induced tolerance
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
NZ517324A (en) 1999-10-11 2003-09-26 Pfizer 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-YL)- dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
ATE433978T1 (de) 2003-04-29 2009-07-15 Pfizer Ltd 5,7-diaminopyrazolo 4,3-d pyrimidine zur verwendung in der behandlung von bluthochdruck
AU2004274403A1 (en) * 2003-09-03 2005-03-31 Aventis Pharmaceuticals Inc. 5-aryl-Pyrazolo(4,3-d)pyrimidines, pyridines, and pyrazines and related compounds
KR20140103925A (ko) 2011-12-09 2014-08-27 키에시 파르마슈티시 엣스. 피. 에이. 4-히드록시-1,2,3,4-테트라히드로나프탈렌-1-일 우레아 및 호흡기 질환의 치료에서의 이들의 용도
CN104540830A (zh) * 2012-06-07 2015-04-22 霍夫曼-拉罗奇有限公司 端锚聚合酶的吡唑并嘧啶酮和吡唑并吡啶酮抑制剂
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
AU2017388054B2 (en) 2016-12-28 2022-03-24 Dart Neuroscience, Llc Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors
KR102794907B1 (ko) 2017-11-27 2025-04-14 다트 뉴로사이언스, 엘엘씨 Pde1 억제제로서의 치환된 푸라노피리미딘 화합물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165520A (en) * 1965-01-12 Certificate of correction
US3211732A (en) * 1965-10-12 Pyrazolob:x-d]pyrlil/hdines
CH398626A (de) * 1960-05-11 1966-03-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
GB937722A (en) * 1960-05-11 1963-09-25 Ciba Ltd New pyrazolopyrimidines and process for the preparation thereof
GB1284084A (en) * 1969-04-17 1972-08-02 Delmar Chem PROCESS FOR MAKING 1H-PYRAZOLO[3,4-d]PYRIMIDINES
US3732225A (en) * 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
US4666908A (en) * 1985-04-05 1987-05-19 Warner-Lambert Company 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
US5075310A (en) * 1988-07-01 1991-12-24 Smith Kline & French Laboratories, Ltd. Pyrimidone derivatives as bronchodilators
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9121028D0 (en) * 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
GB9315017D0 (en) * 1993-07-20 1993-09-01 Glaxo Lab Sa Chemical compounds

Also Published As

Publication number Publication date
HUP9801394A3 (en) 2000-07-28
AU708809B2 (en) 1999-08-12
WO1996028448A1 (en) 1996-09-19
US5736548A (en) 1998-04-07
KR19980702892A (ko) 1998-08-05
CA2211729A1 (en) 1996-09-19
EP0813534A4 (en) 1998-06-10
PL322452A1 (en) 1998-02-02
HUP9801394A2 (hu) 1998-10-28
CZ280697A3 (cs) 1998-04-15
MX9706878A (es) 1998-06-28
AU5093396A (en) 1996-10-02
NO974150D0 (no) 1997-09-09
US5958929A (en) 1999-09-28
JPH11501926A (ja) 1999-02-16
NO974150L (no) 1997-11-07
NZ303886A (en) 1998-11-25
EP0813534A1 (en) 1997-12-29

Similar Documents

Publication Publication Date Title
ZA961948B (en) 6-aryl pyrazoloÚ3,4-d¾pyrimidin-4-ones and compositions and methods of use thereof
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
MX192025B (en) Cosmetic composition, preparation and application of same
ZA964934B (en) Hydrotreating catalyst composition preparation and use thereof
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
GB9526560D0 (en) Use of 2-Amino-Heterocycles
HUP9900334A3 (en) Detergent cosmetic hair-care compositions, and use thereof
HUP9801910A3 (en) Dolastatin derivatives, their preparation and use
GB9506039D0 (en) Underarm compositions
ZA971964B (en) Azolobenzazepine derivatives and compositions and method of use thereof.
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
GB9525812D0 (en) Composition and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
IL117981A0 (en) Compositions containing 2-oxetanones their preparation and use
EP0736578A3 (en) Coating composition and its use
HUP9802997A3 (en) Antisudorific and/or deodorant compositions
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
EP1374894A3 (en) Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and their methods of use
GB9521990D0 (en) Underarm compositions
NZ323282A (en) N,n'-bridged bisindolylmaleimides and their use to prepare n,n'-bridged bisindolylmaleimides
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use